for a while. The owner has been mopping up shares in the open market and the stock has been knocking on the $30 ceiling for a while now. With the FDA granting approval for their machine last quarter, it appears that the company is set to prosper. Last week, it knocked on the $30 ceiling again and looked set to bust through. It was rejected. I can see the stock trading sideways for another few weeks at wave 4 before busting through. The inverted HnS pattern has a target of $54. I am long Feb 2018 $30 calls.